2004
DOI: 10.1186/bcr801
|View full text |Cite
|
Sign up to set email alerts
|

The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer

Abstract: Introduction The etiology of familial breast cancer is complex and involves genetic and environmental factors such as hormonal and lifestyle factors. Understanding familial aggregation is a key to understanding the causes of breast cancer and to facilitating the development of effective prevention and therapy. To address urgent research questions and to expedite the translation of research results to the clinical setting, the National Cancer Institute (USA) supported in 1995 the establishment of a novel resear… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
262
1

Year Published

2004
2004
2024
2024

Publication Types

Select...
10

Relationship

2
8

Authors

Journals

citations
Cited by 260 publications
(263 citation statements)
references
References 28 publications
0
262
1
Order By: Relevance
“…The Breast Cancer Family Registry is described in detail elsewhere. 21 Additional methodologic details from 2 of the study sites have also been published elsewhere. [22][23][24][25] The analysis was based on Caucasian women with a first primary invasive breast cancer who were compared to their sisters and Caucasian women from the general population without a personal history of breast cancer.…”
Section: Methodsmentioning
confidence: 99%
“…The Breast Cancer Family Registry is described in detail elsewhere. 21 Additional methodologic details from 2 of the study sites have also been published elsewhere. [22][23][24][25] The analysis was based on Caucasian women with a first primary invasive breast cancer who were compared to their sisters and Caucasian women from the general population without a personal history of breast cancer.…”
Section: Methodsmentioning
confidence: 99%
“…Eligible subjects were living non-Hispanic white women aged less than 50 years who carried a deleterious mutation in either BRCA1 or BRCA2 and were ascertained from the Breast Cancer Family Registry (Breast CFR), a consortium of research groups in the United States, Australia, and Canada [15], the Kathleen Cuningham Consortium for Research into Familial Breast Cancer (kConFab), Australia and New Zealand (Australasia) [16], and the Ontario Cancer Genetics Network (OCGN), Canada. All sites collected pedigree and epidemiologic risk factor data and biospecimens.…”
Section: Participating Subjects and Sitesmentioning
confidence: 99%
“…The study population was selected from families participating in the New York site of the Breast Cancer Family Registry (BCFR). 24 The New York site of the BCFR recruited high risk breast and/or ovarian cancer families from cancer clinics within the Metropolitan New York area. Families were eligible to participate if the family had at least one of the following: (1) a female relative with breast or ovarian cancer diagnosed before age 45 years, (2) a female relative with both breast and ovarian cancer regardless of age at diagnosis, (3) two or more relatives with breast or ovarian cancer diagnosed after age 45 years, (4) a male with breast cancer diagnosed at any age or (5) a family member with a known BRCA mutation.…”
Section: Methodsmentioning
confidence: 99%